Cite
HARVARD Citation
Neiveyans, M. et al. (2019). A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions. MAbs. 11 (3), pp. 593-605. [Online].